BETA-AMYLOID PRECURSOR PROTEIN (APP) AND APP-RNA ARE RAPIDLY AFFECTEDBY GLUTAMATE IN CULTURED NEURONS - SELECTIVE INCREASE OF MESSENGER-RNAS ENCODING A KUNITZ PROTEASE INHIBITOR DOMAIN
Da. Willoughby et al., BETA-AMYLOID PRECURSOR PROTEIN (APP) AND APP-RNA ARE RAPIDLY AFFECTEDBY GLUTAMATE IN CULTURED NEURONS - SELECTIVE INCREASE OF MESSENGER-RNAS ENCODING A KUNITZ PROTEASE INHIBITOR DOMAIN, Journal of molecular neuroscience, 6(4), 1995, pp. 257-276
Alternative splicing of beta-amyloid precursor protein (APP) RNA gener
ates APP isoforms with or without a Kunitz protease inhibitor (KPI) do
main. Previously, we showed that KPI (+) APP RNA, but not KPI (-) APP
RNA, is upregulated in response to experimental lesions in which neuro
toxicity is dependent on NMDA receptor activation and in Alzheimer's d
isease hippocampus. Recent studies by Mucke et al. (1995) showed that
neuronal expression of human KPI (+) APP, but not KPI (-) APP, in tran
sgenic mice is neuroprotective against experimental lesions. In this s
tudy we examined the direct effects of the excitotoxic amino acid Glu
on alternatively spliced APP RNAs and the corresponding protein isofor
ms in cultured rat cortical neurons. Glu treatment rapidly induced (4.
5 h) KPI (+) APP RNA but not KPI (-) APP RNA. Induction of KPI (+) RNA
preceded Glu-induced neuronal cell death and was partially blocked by
an NMDA-receptor antagonist. In contrast to the RNA, cellular levels
of KPI (+) APP were not changed by 4.5 h of Glu treatment. Instead, th
e cellular full-length form of the protein KPI (-) APP was reduced by
similar to 50% after 2 h of Glu treatment and remained depleted after
24 h of treatment. Cellular levels of KPI (+) forms of amyloid precurs
or-like protein 2 (APLP2) were not changed by Glu treatment. Our data
are consistent with the hypothesis that sustained NMDA-receptor activa
tion can regulate alternative splicing of the APP pre-mRNA in neurons.